Molecular profiles of endometrial cancer tumors among Black patients-Reference-Cited by-同舟云学术

Molecular profiles of endometrial cancer tumors among Black patients

Published:2022-07 Issue:1 Volume:166 Page:108-116
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Wilhite Annelise M.,Baca Yasmine,Xiu Joanne,Paladugu Rajesh,ElNaggar Adam C.,Brown Jubilee,Winer Ira S.,Morris Robert,Erickson Britt K.,Olawaiye Alexander B.,Powell Matthew,Korn W. Michael,Rocconi Rodney P.,Khabele Dineo,Jones Nathaniel L.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference47 articles.

1. Cancer statistics, 2021;Siegel;CA Cancer J. Clin.,2021

2. Annual report to the nation on the status of cancer, Part 1: national cancer statistics;Islami;J. Natl. Cancer Inst.,2021

3. Recent changes in endometrial cancer trends among menopausal-age US women;Wartko;Cancer Epidemiol.,2013

4. Trends in endometrial cancer incidence by race and histology with a correction for the prevalence of hysterectomy, SEER 1992 to 2008;Jamison;Cancer Epidemiol. Biomark. Prev.,2013

5. Assessing endometrial cancer risk among US women: long-term trends using hysterectomy-adjusted analysis;Doll;Am. J. Obstet. Gynecol.,2019

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estrogen and progesterone receptor expression: Impacts on platinum sensitivity and survival outcomes in high‐grade serous ovarian cancer;Malignancy Spectrum;2024-08-04

2. circRNAs in Endometrial Cancer—A Promising Biomarker: State of the Art;International Journal of Molecular Sciences;2024-06-09

3. ARID1A in Gynecologic Precancers and Cancers;Reproductive Sciences;2024-05-13

4. Changing trends in the disease burden of uterine cancer globally from 1990 to 2019 and its predicted level in 25 years;Frontiers in Oncology;2024-04-22

5. Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials;Gynecologic Oncology;2024-04